CoChat

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Open access
Gonzalez-Paz, Natalia, Chng, Wee J., McClure, Rebecca F., Blood, Emily, Oken, Martin M., Ness, Brian Van, James, C. David, Kurtin, Paul J., Henderson, Kimberly, Ahmann, Gregory J., Gertz, Morie, Lacy, Martha, Dispenzieri, Angela, Greipp, Philip R., Fonseca, Rafael · 2007 · Blood
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The biological and clinical implications of p16 gene methylation in multiple myeloma (MM) are still unclear despite previous studies. In this comprehensive study, using methylation-specific PCR (MS-PCR), we show that p16 methylation is relatively common and occurs in monoclonal gammopathy of undetermined significance (MGUS; n = 17), smoldering multiple myeloma (SMM; n = 40), and MM (n = 522) at a prevalence of 24%, 28%, and 34%, respectively. However, p16 methylation does not appear to affect gene expression level. In a large cohort of patients with long-term follow-up information (n = 439), there was no difference in overall survival between patients with or without p16 methylation. We also found no association between p16 methylation and the main cytogenetic categories, although it was more common among patients with 17p13.1 deletions (p53 locus), a genetic progression event in MM. In addition, p16 methylation has no apparent effect on the cycle because there was also no difference in the plasma cell labeling index (a direct measurement of proliferation) between patients with and without p16 methylation. Our results question a major role for p16 methylation in the oncogenesis of the PC neoplasm, and we now believe p16 methylation may be a marker for overall epigenetic changes associated with disease progression, with no obvious direct biological or clinical consequences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2006-05-024661

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 94

Metadata

Authors
Gonzalez-Paz, N., Chng, W. J., McClure, R. F., Blood, E., Oken, M. M., Ness, B. V., James, C. D., Kurtin, P. J., Henderson, K., Ahmann, G. J., Gertz, M., Lacy, M., Dispenzieri, A., Greipp, P. R., & Fonseca, R.
Venue
Blood
Published
2006-07-13
Volume
109
Issue
3
Pages
1228-1232
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2030808959
Cited by
94
References
4
FWCI
5.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications. https://app.cochat.ai/papers/10.1182/blood-2006-05-024661
The paper
Gonzalez-Paz, N., Chng, W. J., McClure, R. F., Blood, E., Oken, M. M., Ness, B. V., James, C. D., Kurtin, P. J., Henderson, K., Ahmann, G. J., Gertz, M., Lacy, M., Dispenzieri, A., Greipp, P. R., & Fonseca, R. (2007). Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications. Blood. https://doi.org/10.1182/blood-2006-05-024661

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.